NCT03709654View on ClinicalTrials.gov

A Study of the Safety, Engraftment, and Action of Multi-Dosed NB01 in Adults With Moderate Acne

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

November 1, 2018

Primary Completion Date

September 30, 2019

Study Completion Date

September 30, 2019

Conditions
Acne Vulgaris
Interventions
BIOLOGICAL

NB01

5-7 day pretreatment of gold standard benzoyl peroxide therapy to kill resident facial bacterial followed by 11 weeks of daily topical application of NB01

OTHER

Vehicle Control

5-7 day pretreatment of gold standard benzoyl peroxide therapy to kill resident facial bacterial followed by 11 weeks of daily topical application of vehicle control

Trial Locations (3)

76011

01, Arlington

78759

02, Austin

92123

03, San Diego

Sponsors

Lead Sponsor

Naked Biome, Inc.
All Listed Sponsors
collaborator

Therapeutics, Inc.

INDUSTRY

lead

Naked Biome, Inc.

INDUSTRY

NCT03709654 - A Study of the Safety, Engraftment, and Action of Multi-Dosed NB01 in Adults With Moderate Acne | Biotech Hunter | Biotech Hunter